<qa>  What is the maximum exposure time for mTOR or PI3K inhibitor?1. Previous treatment with a CDK46 inhibitor, mTOR or PI3K inhibitor, fulvestrant or capecitabine. Short-term 28 days exposure to mTOR or PI3K inhibitor in the neoadjuvant setting is allowed. 